Core binding factor acute myeloid leukemia.
Marcucci
Guido
G
College of Medicine and Public Health, Internal Medicine Hematology/Oncology, Ohio State University, Columbus, OH, USA.
D000208:Acute Disease; D050660:Core Binding Factors / Q000187:drug effects / Q000235:genetics*; D003561:Cytarabine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics*; D018365:Neoplasm, Residual / Q000188:drug therapy / Q000235:genetics; D011379:Prognosis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D050660:Core Binding Factors; D003561:Cytarabine